<b><i>Introduction:</i></b> Inhibitor of growth 4 (ING4) is a tumor suppressor. However the role of ING4 in human bladder malignancy is unknown. In this study, ING4 expression in human bladder cancer and its potential effects were studied. <b><i>Materials and Methods:</i></b> ING4 expression in 47 human bladder cancer tissues and paired adjacent normal tissues was detected by Western blotting, quantitative reverse transcription-polymerase chain reaction, and immunohistochemistry. The migration and cell cycle progression of SV-HUC-1 and T24 cells with aberrant ING4 expression were examined. <b><i>Results:</i></b> ING4 protein and mRNA were significantly decreased in bladder cancer tissues. ING4 protein level was significantly lower in the gr...
Objectives: The objectives of this study were to provide an outlook of urothelial carcinoma through ...
International audienceOBJECTIVE: Investigating whether extracellular factors are possible actors in ...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
Inhibitor of growth 4 (ING4), a member of the conserved ING family, has been identified as an import...
We recently identified the tumor suppressor, Ing4, as a critical regulator of hematopoietic stem cel...
Inhibitor of growth (ING) 4 has been reported as a tumor sup-pressor and shown to diminish colony-fo...
International audienceBackground - Although the founding members of the INhibitor of Growth (ING) fa...
AbstractThe known members of inhibitor of growth (ING) gene family are considered as candidate tumor...
Testicular nuclear receptor 4 (TR4) is a member of the nuclear hormone receptor family and acts as a...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world. The evol...
Abstract: OCT4 (octamer-binding transcription factor) is a transcription factor responsible for main...
Abstract: Background: Bromodomain 4 (BRD4) protein is a double bromodomain-containing protein that b...
Purpose: We demonstrated that amylo-alpha-1-6-glucosidase-4-alpha-glucanotransferase (AGL) is a tumo...
Bladder cancer, one of the most prevalent malignancies worldwide, remains hard to classify due to a ...
International audienceBackground: The insulin growth factor (IGF) pathway has been proposed as a pot...
Objectives: The objectives of this study were to provide an outlook of urothelial carcinoma through ...
International audienceOBJECTIVE: Investigating whether extracellular factors are possible actors in ...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
Inhibitor of growth 4 (ING4), a member of the conserved ING family, has been identified as an import...
We recently identified the tumor suppressor, Ing4, as a critical regulator of hematopoietic stem cel...
Inhibitor of growth (ING) 4 has been reported as a tumor sup-pressor and shown to diminish colony-fo...
International audienceBackground - Although the founding members of the INhibitor of Growth (ING) fa...
AbstractThe known members of inhibitor of growth (ING) gene family are considered as candidate tumor...
Testicular nuclear receptor 4 (TR4) is a member of the nuclear hormone receptor family and acts as a...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world. The evol...
Abstract: OCT4 (octamer-binding transcription factor) is a transcription factor responsible for main...
Abstract: Background: Bromodomain 4 (BRD4) protein is a double bromodomain-containing protein that b...
Purpose: We demonstrated that amylo-alpha-1-6-glucosidase-4-alpha-glucanotransferase (AGL) is a tumo...
Bladder cancer, one of the most prevalent malignancies worldwide, remains hard to classify due to a ...
International audienceBackground: The insulin growth factor (IGF) pathway has been proposed as a pot...
Objectives: The objectives of this study were to provide an outlook of urothelial carcinoma through ...
International audienceOBJECTIVE: Investigating whether extracellular factors are possible actors in ...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...